ghk-cu injection protocol Peptide Therapy: The Definitive Clinical Guide to Gene Modulation, Protocols, and Efficacy GHK-CU Peptide Dosage: Complete Guide

Timing Optional Marker ESR Why it matters Adds another broad inflammation marker when symptoms, autoimmune history, or persistent swelling are part of the picture

National Health Service

From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown

These early changes, while modest, often signal that the peptide is producing physiological effects